Discover a clinical trial that was conducted to evaluate the efficacy and safety of autologous HBV vaccine-pulsed dendritic cells and their induced T cells.
Bepirovirsen sodium is under clinical development by GSK and currently in Phase III for Hepatitis B. According to GlobalData, Phase III drugs for Hepatitis B have a 41% phase transition success rate ...